A major advance in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in various forms of tumors, leading uncontrolled https://livebackpage.com/story7474075/nanobodies-restore-p53-new-new-pathway-for-cancer-therapy